Opinion: Should Human-Animal Chimeras Be Granted “Personhood”?

Determining which products of advanced biotechnology are deserving of legal protections is essential to our own social architecture.

Written byJohn D. Loike
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ISTOCK, LEPTOSPIRAThere are several emerging biotechnologies that raise ethical questions regarding the definition of personhood. One of these innovations is xenotransplantation, which uses gene editing (CRISPR-Cas9) and stem cell technologies to create human-pig or human-sheep chimeras that can grow human organs for transplantation. While most people understand that pigs growing human livers and kidneys could save lives, there is an ethical fear that these technologies may generate animals that incorporate human cells into their brains or sex organs—situations that require broader discussions regarding the question whether such organisms attain the status of personhood.

For example, is there a percent composition of human neurons incorporated into an animal’s brain that renders such a chimera human? Similarly, other stem cell technologies exist to create mice that produce human sperm or eggs. If human gametes from these mice are used to generate a healthy baby, would that baby be considered human?

Human status and personhood have different meanings. Biologically, the term “human being” refers to an animal that genetically belongs to the species Homo sapiens. Many religious scholars include “ensoulment”—defined as the instant a human being attains a soul—as a characteristic of human status. In general, personhood denotes a set of capacities that imply both the ability to engage in certain sophisticated behaviors and an elevated moral standing deserving of certain ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • John Loike

    John Loike serves as the interim director of bioethics at New York Medical College and as a professor of biology at Touro University. He served previously as the codirector for graduate studies in the Department of Physiology Cellular Biophysics and director of Special Programs in the Center for Bioethics at Columbia University College of Physicians and Surgeons. His biomedical research focuses on how human white blood cells combat infections and cancer. Loike lectures internationally on emerging topics in bioethics, organizes international conferences, and has published more than 150 papers and abstracts in the areas of immunology, cancer, and bioethics. He earned his Ph.D. from the Albert Einstein College of Medicine of Yeshiva University.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery